Vijaya Diagnostic Centre liquidity ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
18.63×————
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
2.60×2.60×1.89×2.90×4.17×
2.56×2.56×1.86×2.83×4.14×
268268197131163
198198145138209
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

VIJAYA₹1,464.20

Vijaya Diagnostic Centre Ltd.

· Pharma & Health
₹ CrorePeersTHYROCAREMETROPOLISLALPATHLABRAINBOWPOLYMEDPFIZERONESOURCEKIMSMcap ₹15,066 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Altman Z-Score (Other Equity as RE)————18.63
Current Ratio4.172.901.892.602.60
Quick Ratio4.142.831.862.562.56
Cash, Equiv & ST Investments163.2131.4197.4268.1268.1
Working Capital209.5138.5144.6198.0198.0
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.